Evie Koslosky
Stock Analyst at Goldman Sachs
(0.86)
# 3,759
Out of 4,417 analysts
19
Total ratings
46.2%
Success rate
-6.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Evie Koslosky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Initiated Coverage: Hold | $245 | $226.44 | +8.20% | 1 | Jun 5, 2026 | |
| GH Guardant Health | Initiated Coverage: Buy | $165 | $129.11 | +27.80% | 1 | Jun 5, 2026 | |
| SHC Sotera Health Company | Initiated Coverage: Buy | $20 | $15.46 | +29.37% | 1 | Jun 5, 2026 | |
| GRAL GRAIL | Initiated Coverage: Hold | $60 | $59.45 | +0.93% | 1 | Jun 5, 2026 | |
| A Agilent Technologies | Maintained: Buy | $150 → $155 | $124.33 | +24.67% | 3 | May 27, 2026 | |
| MTD Mettler-Toledo International | Maintained: Hold | $1,475 → $1,400 | $1,129.53 | +23.95% | 2 | May 8, 2026 | |
| RVTY Revvity | Maintained: Hold | $105 → $100 | $97.82 | +2.23% | 2 | May 6, 2026 | |
| WAT Waters | Reiterated: Buy | $375 → $380 | $357.00 | +6.44% | 2 | May 6, 2026 | |
| DHR Danaher | Maintained: Buy | $265 → $230 | $177.76 | +29.39% | 2 | Apr 21, 2026 | |
| CAI Caris Life Sciences | Initiated Coverage: Buy | $27 | $17.86 | +51.18% | 1 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $40 → $35 | $54.73 | -36.05% | 2 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $685 | $461.69 | +48.37% | 1 | Dec 9, 2025 |
Natera
Jun 5, 2026
Initiated Coverage: Hold
Price Target: $245
Current: $226.44
Upside: +8.20%
Guardant Health
Jun 5, 2026
Initiated Coverage: Buy
Price Target: $165
Current: $129.11
Upside: +27.80%
Sotera Health Company
Jun 5, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $15.46
Upside: +29.37%
GRAIL
Jun 5, 2026
Initiated Coverage: Hold
Price Target: $60
Current: $59.45
Upside: +0.93%
Agilent Technologies
May 27, 2026
Maintained: Buy
Price Target: $150 → $155
Current: $124.33
Upside: +24.67%
Mettler-Toledo International
May 8, 2026
Maintained: Hold
Price Target: $1,475 → $1,400
Current: $1,129.53
Upside: +23.95%
Revvity
May 6, 2026
Maintained: Hold
Price Target: $105 → $100
Current: $97.82
Upside: +2.23%
Waters
May 6, 2026
Reiterated: Buy
Price Target: $375 → $380
Current: $357.00
Upside: +6.44%
Danaher
Apr 21, 2026
Maintained: Buy
Price Target: $265 → $230
Current: $177.76
Upside: +29.39%
Caris Life Sciences
Apr 1, 2026
Initiated Coverage: Buy
Price Target: $27
Current: $17.86
Upside: +51.18%
Feb 13, 2026
Maintained: Sell
Price Target: $40 → $35
Current: $54.73
Upside: -36.05%
Dec 9, 2025
Initiated Coverage: Buy
Price Target: $685
Current: $461.69
Upside: +48.37%